|

JANX014 Clinical Trials

1 actively recruiting trial across 1 location

No change since August 2026

Pipeline

Phase 1: 1

Top Sponsors

  • Janux Therapeutics1

Indications

  • Castration-resistant Prostate Cancer1
  • Metastatic Castration-resistant Prostate Cancer1
  • Prostate Cancer1
  • Cancer1

La Jolla, California1 trial

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

UC San Diego Moores Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.